Abstract |
Multiple mechanisms related to metastases undergo redox regulation. Cu[ 15]pyN5 is a redox-active copper(II) complex previously studied as a chemotherapy sensitizer in mammary cells. The effects of a cotreatment with Cu[ 15]pyN5 and doxorubicin (dox) were evaluated in two human breast cancer cell lines: MCF7 (low aggressiveness) and MDA-MB-231 (highly aggressive). Cu[ 15]pyN5 decreased MCF7-directed cell migration. In addition, a cotreatment with dox and Cu[ 15]pyN5 reduced the proteolytic invasion of MDA-MB-231 cells. Cell detachment was not affected by exposure to these agents. Cu[ 15]pyN5 and dox significantly increased intracellular ROS in both cell lines. This increase could be at least partially due to H2 O2 accumulation. The combination of Cu[ 15]pyN5 with dox may be beneficial in breast cancer treatment as it could help reduce cancer cell migration and invasion. Moreover, the ligand [ 15]pyN5 has a high affinity for copper(II) and displays potential anti-angiogenic properties. Overall, we present a potential drug that might arrest the progression of breast cancer by different and complementary mechanisms.
|
Authors | Ana S Fernandes, Ana Flórido, Nuno Saraiva, Sara Cerqueira, Sérgio Ramalhete, Madalena Cipriano, Maria Fátima Cabral, Joana P Miranda, Matilde Castro, Judite Costa, Nuno G Oliveira |
Journal | Chemical biology & drug design
(Chem Biol Drug Des)
Vol. 86
Issue 4
Pg. 578-88
(Oct 2015)
ISSN: 1747-0285 [Electronic] England |
PMID | 25600158
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2015 John Wiley & Sons A/S. |
Chemical References |
- Antineoplastic Agents
- Reactive Oxygen Species
- Copper
- Doxorubicin
|
Topics |
- Antineoplastic Agents
(chemistry, pharmacology)
- Breast Neoplasms
(drug therapy, metabolism, pathology)
- Cell Movement
(drug effects)
- Copper
(chemistry, pharmacology)
- Doxorubicin
(chemistry, pharmacology)
- Female
- Humans
- MCF-7 Cells
- Reactive Oxygen Species
(metabolism)
|